腎移植感染症マニュアル

出版社: 東京医学社
著者:
発行日: 2013-02-15
分野: 臨床医学:内科  >  腎臓
ISBN: 9784885632204
電子書籍版: 2013-02-15 (第1版)
書籍・雑誌
≪全国送料無料でお届け≫
発送目安:8~14営業日

5,060 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

5,060 円(税込)

商品紹介

腎移植への準備はCKD早期から。感染症マネージメントにより腎移植患者の予後は改善。腎臓内科医をはじめとする腎疾患を診る医師に必須の1冊。

目次

  • 表紙
  • 編集 / 執筆者
  • 序文
  • はじめに
  • 目次
  • 総論
  • 最近の免疫抑制薬における腎移植と感染症
  • 一般人の感染症と臓器移植後感染症の違いと対応
  • 腎移植後感染症の発症時期
  • 腎移植前の評価
  • ドナー由来の感染症
  • 腎移植術に伴う感染症
  • 特殊な環境下の感染症
  • 小児に特徴的な感染症
  • 臓器別
  • 01 頭部感染症
  • 02 血流感染症
  • 03 皮膚軟部組織感染症
  • 04 胸部感染症
  • 05 腹部感染症
  • 06 尿路感染症
  • 病原体別
  • 01 サイトメガロウイルス
  • 02 Epstein - Barrウイルス
  • 03 単純ヘルペスウイルス, 水痘・帯状疱疹ウイルス
  • 04 ヒトパピローマウイルス
  • 05 B型肝炎ウイルス
  • 06 C型肝炎ウイルス
  • 07 ヒトT細胞白血病ウイルス1型
  • 08 BKウイルス
  • 09 JCウイルス
  • 10 RSウイルス・インフルエンザウイルス
  • 11 カンジダ
  • 12 アスペルギルス
  • 13 クリプトコッカス
  • 14 ニューモシスチスイロベチイ
  • 15 結核菌
  • 16 非結核性抗酸菌
  • 17 クロストリジウム・ディフィシル
  • 18 アデノウイルス
  • 19 ヘリコバクター・ピロリ
  • 20 ヒト免疫不全ウイルス
  • 予防その他
  • 抗菌薬予防投与
  • ワクチン接種 ( 成人 )
  • ワクチン接種 ( 小児 )
  • トラベル医学
  • 移植後のペット, 食事
  • 抗菌薬と免疫抑制薬の相互作用
  • 感染コントロール ( 市中感染 )
  • 索引
  • 奥付

おすすめ商品

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

総論

P.11 掲載の参考文献
3. ePocrates. Available from : http://www.epocrates.com/
5. The Sanford guide to antimicrobial therapy 2011. 39th ed. Sanford Guide (R)
6. 厚生労働科学研究費補助金厚生労働科学特別研究事業「臓器提供施設における院内体制整備に関する研究」臓器提供施設のマニュアル化に関する研究. 臓器提供施設マニュアル平成22年度. Available from : http://www.jotnw.or.jp/jotnw/law_manual/index.html
7. IDATENセミナーテキスト編集委員会. 病院内/免疫不全関連感染症診療の考え方と進め方 (IDATEN感染症セミナー). 東京 : 医学書院, 2011.
P.15 掲載の参考文献
3. Southwick FS (編), 青木眞 (監). 感染症診療スタンダードマニュアル 第2版. 東京 : 羊土社, 2011
7. Naqvi SA, Hussain M, Askari H, Hashmi A, Hussain Z, Hussain I, Hafiz S, Yazdani I, Rizvi SA. Is there a place for prophylaxis against tuberculosis following renal transplantation? Transplant Proc 1992 ; 24 (5) : 1912.
P.22 掲載の参考文献
P.28 掲載の参考文献
7. Natov SN, Lau JY, Ruthazer R, Schmid CH, Levey AS, Pereira BJ. Hepatitis C virus genotype does not affect patient survival among renal transplant candidates. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1999 ; 56 (2) : 700-6.
14. Kumar A, Humar A. The AST Handbook of Transplant Infections. America Society of Transplantation. 93-6.
P.33 掲載の参考文献
P.38 掲載の参考文献
7. Baseler M, Lauer C, Beck U, Groettrup M. The proteasome inhibitor bortezomib enhances the susceptibility to viral infection. J Immunol 2009 ; 183 : 6145-50.
14. Schonermarck U, Kauke T, Jager G, Habicht A, Wendler T, Andrassy J, Guba M, Stangl M, Fischereder M. Effect of apheresis for ABO and HLA desensitization on anti-measles antibody titers in renal transplantation. J Transplant 2011 ; Epub 2011 Dec 8.
P.43 掲載の参考文献
3. Martin-Pena A, Cordero E, Fijo J, et al. Prospective study of infectious complications in a cohort of pediatric renal transplant recipients. Transplantation 2000 ; 69 : 1617-23.
10. Hebert D, Sulivan EK. Malignancy and posttransplant lymphoproliferative disorder (PTLD) in pediatric renal transplant recipients : a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1998 ; 2 (Suppl 1) : 57 (Abstract).

臓器別

P.53 掲載の参考文献
10. Khin-Sane-Win, Matsumura T, Kumagai S, Uga S, Konishi E. Prevalence of antiboy to Toxoplasma gondii in Hyogo prefecture, Japan : comparison at a 10-year interval. Kobe J Med Sci 1997 ; 43 : 159-68.
15. Bowden RA. Transplant Infections 3rd ed. Ljungman P, Snydman DR (eds) ; Chapter 17, Lippincott Williams & Wilkins, 2010 : 226.
P.57 掲載の参考文献
7. 鈴木利保 (訳). 血管内留置カテーテル, ICUブック, 稲田英一 (監訳), 東京 : メディカル・サイエンス・インターナショナル, 2008 : 112-8.
8. 中村守男 (訳). 血管内カテーテル関連感染症, 感染症診療スタンダードマニュアル, 青木眞 (監), 東京 : 羊土社, 2007 : 251-5.
10. Kidney Disease : Improving Global Outcomes (KDIGO) TransplantWork Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009 ; 9 (Suppl 3) : S1-155.
11. 藤本卓司. 血管内カテーテル関連感染症, 感染症レジデントマニュアル, 東京 : 医学書院, 2004 : 119-24.
12. O'Grady NP, AlexanderM, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011 ; 52 : 162-93.
P.64 掲載の参考文献
1. IDATENセミナーテキスト編集委員会 (編). 市中感染症診療の考え方と進め方IDATEN感染症セミナー, 東京 : 医学書院, 37-54.
2. 青木眞. 皮膚・軟部組織感染症. レジデントのための感染症診療マニュアル第2版, 東京 : 医学書院, 2008 : 757-818.
11. Sjoblom AC, Eriksson B, Jorup-Ronstrom C, et al. Antibiotic prophylaxis in recurrent erysipelas. Infection 1993 ; 21 : 390.
14. Mazen S, Lawrence E, Daniel WP. Skin infections after hemopoietic stem cell or solid organ transplantation. Raleigh A. Bowden. Per Ljungman David R. Snydman. Transplant Infections 3rd ed. 2010 : 203-13.
P.70 掲載の参考文献
6. Southwick FS (編), 青木眞, 喜舎場朝和 (監). 感染症診療スタンダードマニュアル 第2版. 東京 : 羊土社, 2011.
7. Mandell GL, et al. Principles and practice of infectious diseases. 7th ed. Churchill Livingstone : Elsevier, 2009, Chapter 312, table 312-3.
14. Bowden RA, Ljungman P, Snydman DR. Transplant Infections 3rd ed. (eds), Lippincott Williams&Wilkins, 2010 : 187-96.
15. Cordonnier C, Cunningham I. Pneumonia after hematopoietic stem cell or solid organ transplantation. Transplant Infections. 3rd ed Lippincott Williams & Wilkins, 2010 : 187-202.
P.77 掲載の参考文献
1. 多発性嚢胞腎診療指針. 日腎会誌 2011 ; 53 (4) : 556-83.
9. Dominguez Fernandez E, Albrecht KH, Heemann U, Kohnle M, Erhard J, Stoblen F, Eigler FW. Prevalence of diverticulosis and incidence of bowel perforation after kidney transplantation in patients with polycystic kidney disease. Transpl Int 1998 ; 11 (1) : 28-31.
12. Sterling RK. Management of gastrointestinal disease in liver transplant recipients. Gastrointest Endosc Clin N Am 200 ; 11 (1) : 185-97.
15. Stylianos S, Chen MH, Treat MR, LoGerfo P, Rose EA. Colonic lymphoma as a cause of massive rectal bleeding in a cardiac transplant recipient. J Cardiovasc Surg 1990 ; 31 (3) : 315-7.
P.80 掲載の参考文献
5. Memikoglu KO, Keven K, Sengul S, Soypacaci Z, Erturk S, Erbay B. Urinary tract infections following renal transplantation : A singlecenter experience. Transplant Proc 2007 ; 39 : 3131-4.
11. Kasiske BL, Vazquez MA, Harmon WE, et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000 ; 11 (Suppl 15) : S1-86.

病原体別

P.90 掲載の参考文献
3. 大黒徹, 武本眞清, 白木公康. サイトメガロウイルス感染症の基礎研究. 今日の移植 2010 ; 23 (2) : 180-9.
4. Rayes N, Seehofer D, Lullius SG, et al. Monitoring of human cytomegalovirus, HHV-6 and HHV-7 infection in kidney transplant recipients by molecular methods to predict HCMV disease after transplantation : A prospective study. Ann Transplant 2005 ; 10 : 23.
5. Schroeder R, Michelon T, Fagundes I, et al. Antigenemia for cytomegalovirus in renal transplantation : Choosing a cut off for the diagnosis criteria in cytomegalovirus disease. Transplant Proc 2005 ; 37 : 2781-3.
6. The TH, Van der Gij W, Van den Berg AP, et al. Cytomegalovirus antigenemia. Rev Inf Dis 1990 ; 12 (Suppl 7) : s737-44.
8. 渡井至彦. 腎移植における長期生着を目指してウイルス感染. 今日の移植 2010 ; 23 : 90-5.
10. Gerna G, Baldanti F, Torsellini M, et al. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenemia cutoff for guiding preemptive therapy in transplant recipients ; A randomized study. Antivir Ther 2007 ; 12 : 63.
17. KDIGO Clinical practice Guideline for the care of kidney transplant recipients. Am J Transplant 2009 ; 9 (Suppl 3) : S46.
18. 日本臨床腎移植学会ガイドライン作成委員会. 腎移植後サイトメガロウイルス感染症の診療ガイドライン 2011, 東京 : 日本医学館, 2011.
P.96 掲載の参考文献
1. Sullivan JL, Luzuriaga K. Viology of Epstein-Barr virus. UpToDateR 20.2
2. Penn I. De novo malignancies in pediatric organ transplant recipients. Pediatr Transplant 1998 ; 2 : 56-63.
5. Special Issue : KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Epstein-Barr virus and post-transplant lymphoproliferative disease. Am J Transplant 2009 ; 9 (Suppl 3) : S44-58.
8. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988 ; 133 (1) : 173.
10. Krzysztof M, Bartosz F, Bogna Z, et al. Post-transplant lymphoproliferative disorder in view of the new WHO classification : a more rational approach to a protean disease? Nephrol Dial Transplant 2010 ; 25 : 2089-98.
13. Preiksaitis JK, Cockfield SM. Epstein-Barr virus infection and lymphoproliferative disorders after transplantation. Bowden RA, Ljungman P, Snydman DR (eds), Transplant Infections., 3rd ed. Philadelphia : Lippincott Williams & Wilkins, 2010 : 362-90.
P.101 掲載の参考文献
3. Klein RS. Epidemiology of herpes simplex virus type 1 infection. UpToDate 2012 ; 19.
4. Albrecht MA. Epidemiology, clinical manifestations, and diagnosis of genital herpes simplex virus infection. UpToDate 2012 ; 19.3.
6. 国立感染症研究所ホームページ (http://idsc.nih.go.jp/index-j.html) 感染症サーベイランス感染症発生動向調査.
7. Albrecht MA. Epidemiology and pathogenesis of varicella-zoster virus infection : Herpes zoster. UpToDate 2012 ; 19.3.
8. Christiansen NP, Haake RJ, Hurd DD. Early herpes zoster infection in adult patients with Hodgkin's disease undergoing autologous bone marrow transplant. Bone Marrow Transplant 1991 ; 7 : 435-7.
10. Kidney Disease : Improving Global Outcomes (KDIGO) TransplantWork Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009 ; 9 (Suppl 3) : S1-155.
12. Goto N, Kawaguchi T, Watarai Y, et al. A vaccine to prevent herpes zoster in kidney transplantation. Am J Transplant 2011 ; 11 (Suppl 2) : 43.
P.106 掲載の参考文献
3. Dyall-Smith D, Trowell H, Dyall-Smith ML. Benign human papilloma virus infection in renal transplant recipients. Int J Dermatol 1991 ; 30 : 785-9.
9. Sillman FH, Sentovich S, Shaffer D. Anogenital neoplasia in renal transplant patients. Ann Transplant 1997 ; 2 : 59-66.
13. Kaplan JE, Benson C, et al. Centers for Disease Control and Prevention (CDC), National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents : Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009 ; 58 (RR-4) : 1-207.
P.112 掲載の参考文献
6. Chow KM, Szeto CC, Wu AK, et al. Continuous ambulatory peritoneal dialysis in patients with hepatitis B liver disease. Perit Dial Int 2006 ; 26 : 213.
10. Knoll A, Pietrzyk M, Loss M, et al. Solid-organ transplantation in HBsAg-negative patients with antibodies to HBV core antigen : Low risk of HBV reactivation. Transplantation 2005 ; 79 : 1631-3.
15. Mast EE,Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM Jr, Janssen RS, Ward JW ; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States : recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II : immunization of adults. MMWR Recomm Rep 2006 ; 55 (RR-16) : 1-33 ; quiz CE1-4.
P.119 掲載の参考文献
4. Kidney Disease : Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int 2008 ; 73 (Suppl 109) : S1-S99.
5. 透析患者のC型ウイルス肝炎治療ガイドライン. 透析会誌 2011 ; 44 : 481-531.
8. Gursoy M, Guvener N, Koksal R. Impact of HCV infection in development of posttransplantation diabetes mellitus in renal allograft patients. Transplant Proc 2000 ; 32 : 561-72.
12. Fabrizi F, Bunnapradist S, Lunghi G, Martin P. Transplantation of kidneys from HCV-positive donors : a safe strategy. J Nephrol 2003 ; 16 : 617-25.
13. 斉藤純, 矢澤浩治, 角田洋一, 他. HCV-RNA陽性ドナーに対しIFN療法を行い生体腎移植を施行した2例. 移植 2006 ; 41 : 273-6.
P.122 掲載の参考文献
1. Uchiyama T, Yodoi J, Sagawa K, et al. Adult T-cell leukemia : clinical and hematologic features of 16 cases. Blood 1977 ; 50 : 481-92.
4. 厚生労働省科学研究費補助金新型インフルエンザ等新興・再興感染症研究事業「本邦におけるHTLV-1感染及び関連疾患の実態調査と総合対策」研究班 (主任研究者山口一成). 平成21年度総括報告書.
5. 難病情報センター. HTLV-1 関連脊髄症 (HAM), http://www.nanbyou.or.jp/entry/212
6. HTLV-I 母子感染予防対策保健指導マニュアル (改訂版), http://www.mhlw.go.jp/bunya/kodomo/boshi-hoken16/dl/05.pdf
8. 猪瀬悠理, 秋山茂雄, 望月温子, 他. 生体腎移植後にHTLV-1関連脊髄症を発症した1例. 臨床神経 2010 ; 50 : 241-5.
9. (社) 日本臓器移植ネットワークホームページ. ドナー適応基準, http://www.jotnw.or.jp/jotnw/law_manual/pdf/donor%20adjustment%20standard.pdf
10. 日本臨床腎移植学会ホームページ. 生体腎移植ガイドライン, http://www.jscrt.jp/pdf_file/guideline.pdf
12. 細川直登. HTLV-I抗体. 感度と特異度からひもとく感染症診療のDecision Making, 東京 : 文光堂, 254-7.
P.126 掲載の参考文献
5. Kamney E, Mihatsch MJ. Plasma cell infiltrates in polyoma nephropathy. Transplant Intern ISSN 2010 ; 23 : 397-406.
9. 武田朝美, 両角國男, 打田和治. 腎移植の進歩 (4) 腎移植とウイルス感染. 日腎会誌 2004 ; 46 : 661-6.
P.132 掲載の参考文献
2. Lisa M. Epidemiology of JC and BK virus infection. 2012 : 1-3, Up To Date
4. Monaco MC, Jensen PN, Hou J, et al. Detection of JC virus DNA in human tonsil tissue : evidence for site of initial viral infection. J Virol 1998 ; 72 : 9918.
5. Kunitake T, Kitamura T, Guo J, et al. Patient-to-child transmission is relatively common in the spread of the human polyomavirus JC virus. J Clin Microbiol 1995 ; 33 : 1448.
6. Supha K, Raymund R. JC virus infection after transplantation : Beyond the classic progressive multifocal leukoencephalopathy? Gastroenterol Hepatol 2007 ; 3 (1) : 74-6.
9. Igor J. Progressive multifocal leukoencephalopathy : Epidemiology, clinical manifestations, and diagnosis. 2012 : 1-16, Up To Date
10. Igor J. Progressive multifocal leukoencephalopathy : Prognosis and treatment. 2012 : 1-11, Up To Date
P.137 掲載の参考文献
4. Couch RB, Englund JA, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 1997 ; 102 : 2-9. discussion 25-6.
7. Centers for Disease Control and Prevention. Prevention and control of influenza. MMWR 2005 ; 54 (RR08) : 1-40.
8. Michael B, Rothenberg MD, Sarah D. Complications of seasonal and pandemic influenza. Clitical Care Med 2010 ; 38 : 4 : e91-7.
11. 大曲貴夫, 上田晃弘, 藤田崇宏, 他. 免疫不全者の呼吸器感染症. 東京 : 南山堂, 2011 : 285-93.
12. Nickerson CL, Jakob GJ. Pulmonary antibacterial defenses during mild and severe influenza virus infection. Infect Immun 1990 ; 58 : 2809-14.
13. Andrea D, John AG, Saul K, et al. Vaccinations for adult solid-organ transplant recipients : current recommendations and protocols. Clin Microbiol Rev 2003 ; 16 : 357-64.
P.142 掲載の参考文献
3. Murphy JW, Bistoni F, Deepe GS, Blackstock RA, Buchanan K, Ashman RB, Romani L, Mencacci A, Cenci E, Fed'Ostiani C, Del Sero G, Calich VL, Kashino SS. Type 1 and type 2 cytokines : from basic science to fungal infections. Med Mycol 1998 ; 36 (Suppl 1) : 109-18.
8. MitsutakeK, Miyazaki T, Tashiro T, et al. Enolase antigen, mannan, Cand-Tec antigen and b-glucan in patients with candidemia. J Clin Microbiol 1996 ; 34 : 1918-21.
9. 細川直登. 感度と特異度からひもとく感染症診療のDecision Making. カンジダ抗原. 東京 : 文光堂, 2012 : 206-8.
19. Grossi P, Farina C, Fiocchi R, Dalla Gasperina D. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients : a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation 2000 ; 70 : 112-6.
P.148 掲載の参考文献
1. 渋谷和俊, 他. 深在性真菌症の病態と診断. 今日の移植 2009 ; 22 : 368.
2. 青木眞. レジデントのための感染症診療マニュアル (第2版). 東京 : 医学書院, 2008 : 1107.
4. Munoz P, Giannella M, Burillo A, Bouza E. Aspergillus and other mold infections after solid organ transplant. Bowden RA, Ljungman P, Snydman DR (eds) Transplant Infections 3rd ed. 2010 : 554-66.
6. 高倉俊二. 日本における固形臓器移植後の侵襲性アスペルギルス症の現状. シンポジウム「アスペルギルス症への挑戦~診断から治療まで~」第9回真菌症フォーラム, 東京.
7. 堀口祐司. 侵襲性アスペルギルス症の早期診断におけるβ-グルカン測定およびガラクトマンナン抗原測定法の有用性. 感染症学誌 2004 ; 78 : 566.
8. 前崎繁文. 深在性真菌症. Jpn J Antibiot 2005 ; 58 : 368.
9. Walsh TJ, et al. Treatment of Aspergillosis : Clinical Practice Guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008 ; 46 : 327.
P.155 掲載の参考文献
1. 泉川公一. クリプトコックス感染症の治療戦略 (脳髄膜炎以外) 非免疫不全患者における肺クリプトコックス症の治療 ; IDSAガイドライン真菌症治療のUP-TO-DATE, 医薬ジャーナル 2010 : 291-7.
2. Mandell : Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed. Chapter 263, 3287-303.
3. Pappas PG, Kaufmann C, Alexander B, et al. Prospective surveillance of invasive fungal infections (lfls) among organ transplant recipients (OTRs) in the U. S. 2001-2006. 47th Interscience Conference on Anticrobial Agents and Chemotherapy, Chicago, September 17-20, 2007.
5. Tanner DC, Weinstein MP, Fedorciw B, Joho KL, Thorpe JJ, Reller L. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 1994 ; 32 (7) : 1680-4.
P.159 掲載の参考文献
1. Pifer LL, Hughes WT, Stagno S, et al. Pneumocystis carinii infection : evidence for high prevalence in normal and immunosuppressed children. Pediatrics 1978 ; 61 (1) : 35-41.
10. Kidney Disease : Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009 ; 9 (Suppl 3) : S1-155.
12. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus : U. S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA). MMWR Recomm Rep 1999 ; 48 (RR-10) : 1-66.
P.164 掲載の参考文献
1. WHO Global tuberculosis control 2011 http://www.who.int/tb/publications/global_report/en/index.html
2. 日本結核病学会. 結核治療ガイドライン 2009
3. Julia'n Torre-Cisneros, et al. Tuberculosis after solid-organ transplant : incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 2009 ; 48 (12) : 1657.
5. 日本結核病学会予防委員会. クォンティフェロンRTBゴールドの使用指針. 結核 2011 ; 86 (10) : 839-44.
8. 後藤憲彦. 腎移植と結核-潜在性結核感染者に対する移植後モニタリング. 結核 2011 ; 86 (2) : 102-5.
9. Mycobacterium tuberculosis. Am J Transplant 2004 ; 4 (Suppl 10) : 37-41.
10. European best practice guidelines for renal transplantation. Section IV : Long-term management of the transplant recipient. IV. 7.2. Late infections. Tuberculosis. Nephrol Dial Transplant 2002 ; 17 (Suppl 4) : 39-43.
P.169 掲載の参考文献
6. C. Fordham von Reyn. Nontuberculous mycobacteria. Anthony S Fanci, Eugene Braunwald (eds) Harrison's Principles of Internal Medicine 17th ed. New York : McGraw-Hill, 2008 : 1027-32.
7. 青木眞. 非定型抗酸菌症. レジデントのための感染症診療マニュアル 第2版, 東京 : 医学書院, 2008 : 1075-83.
9. Brown BA, Wallace RJ Jr. Infections due to nontuberculous mycobacteria. Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas and Bennet's principles and practice of infectious diseases. 6th ed, Philadelphia : Churchill-Livingstone, 2005 : 3191-8.
10. Griffith DE, Wallace RJ Jr, et al. Overview of nontuberculous mycobacterial infections in HIV-negative patients. UpToDate(R) ver 18.2.
P.177 掲載の参考文献
9. O'Horo J, Safdar N. The role of immunoglobulin for the treatment of Clostridium difficile infection : a systematic review. Int J Infect Dis 2009 ; 13 : 663-7.
10. Enache-Angoulvant A, Hennequin C, et al. Invasive Saccharomyces infection : a comprehensive review. Clin Infec Dis 2005 ; 173 : 167-70.
13. Surveillance or community-associated Clostridium difficile--Connecticut, 2006. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep 2008 ; 57 (13) : 340.
P.181 掲載の参考文献
7. 大塚聡樹. 尿中アデノウイルスに対する免疫クロマト法によるアデノウイルス抗原検出の検討. 移植 2009 ; 44 : 304.
9. 山口裕. 移植腎のウイルス感染性腎症. In : 移植腎病理アトラス. 東京 : 東京医学社, 2005 : 267-75.
P.185 掲載の参考文献
5. Ala-Kaila K. Upper gastrointestinal findings in chronic renal failure. Scand J Gastroenterol 1987 ; 22 : 372-6.
8. Prakash J, Agrawal BK. Upper gastrointestinal mucosal lesions in chronic renal failure. Indian J Gastroenterol 1991 ; 10 : 131-2.
9. Gheissari A, Rajyaguru V, Kumashiro R, Matsumoto T. Gastrointestinal hemorrhage in end stage renal disease patients. Int Surg 1990 ; 75 : 93-5.
12. Milito G, Taccone-Gallucci M, Brancaleone C, et al. Assessment of the upper gastrointestinal tract in hemodialysis patients awaiting renal transplantation. Am J Gastroenterol 1983 ; 78 : 328-31.
13. Milito G, Taccone-Gallucci M, Brancaleone C, et al. The gastrointestinal tract in uremic patients on long-term hemodialysis. Kidney Int 1985 ; 17 (Suppl) : S157-60.
24. Lamouliatte H, Cayla R, Megraud F. Treatment of Helicobacter pylori infection. Rev Prat 2000 ; 50 : 1442-5.
P.191 掲載の参考文献
2. 平成23 (2011) 年エイズ発生動向年報 (http://api-net.jfap.or.jp/status/2011/11nenpo/nenpo_menu.htm)
5. Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-SadrWM, Lundgren J, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, Cohn D, Cooper D, Darbyshire J, Emery S, Fa?tkenheuer G, Gazzard B, Grund B, Hoy J, Klingman K, Losso M, Markowitz N, Neuhaus J, Phillips A, Rappoport C. CD4+count-guided interruption of antiretroviral treatment. N Engl J Med 2006 ; 355 (22) : 2283-96.
6. Weber R, Sabin CA, Friis-Moller N, Reiss P, El-SadrWM, Kirk O, Dabis F, LawMG, Pradier C, DeWit S, Akerlund B, Calvo G, Monforte Ad, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD. Liver-related deaths in persons infected with the human immunodeficiency virus : the D : A : D study. Arch Intern Med 2006 ; 166 (15) : 1632-41.
7. AD Study Group, Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte Ad, El-Sadr W, Thie?baut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007 ; 356 (17) : 1723-35.
8. Strategies for Management of Antiretroviral Therapy (SMART) Study Group, Lundgren JD, Babiker A, El-Sadr W, Emery S, Grund B, Neaton JD, Neuhaus J, Phillips AN. Inferior clinical outcome of the CD4+cell count-guided antiretroviral treatment interruption strategy in the SMART study : role of CD4+ Cell counts and HIV RNA levels during follow-up. J Infect Dis 2008 ; 197 (8) : 1145-55.
9. HIV感染症治療研究会. HIV感染症「治療の手引き」 (http://www.hivjp.org/guidebook/hiv_15.pdf)
10. International Antiviral Society-USA (https://www.iasusa.org/)
17. Lang P, Niaudet P. Update and outcome of renal transplant patients with human immunodeficiency virus. The Groupe Cooperatif de Transplantation de I'lle de France. Transplant Proc 1991 ; 23 : 1352.
19. Roland MS, Carlson L. Liver and kidney transplantation in HIV-infected patients : A preliminary multi-site experience. 9th Conference on Retroviruses and Opportunistic Infections ; February 24-28, 2002 ; Seattle, Washington. Abstract 655.
31. Kumar MSA, Khan SM, Ranganna K, Malat GE, Kumar AMS, Jacobson JM. In HIV+patients with end stage renal disease (ESRD) kidney transplantation significantly prolongs long-term patient survival compared to chronic dialysis treatment. Am J Transplant 2008 ; 8 (Suppl 2) : 179.

予防その他

P.197 掲載の参考文献
1. National Collaboration Centre for Chronic Conditions. Tuberculosis, clinical diagnosis and management. London : Royal College of Physicians, 2006.
4. OestreicherR. Peripheral neuritis in tuberculous patients treated with isoniazid. Am Rev Tuberc 1954 ; 70 : 504.
6. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council. Am Rev Respir Dis 1992 ; 145 : 36.
12. The American Society of Transplantation Infectious Disease Guidelines. Am J Transplant 2009 ; 9 (Suppl 4) : S8.
13. 腎移植後サイトメガロウイルス感染症の診療ガイドライン 2011
14. Schroeder R, Michelon T, Fagundes I, et al. Antigenemia for cytomegalovirus in renal transplantation : Choosing a cut off for the diagnosis criteria in cytomegalovirus disease. Transplant Proc 2005 ; 37 : 2781-3.
15. The TH, Van der Gij W, Van den Berg AP, et al. Cytomegalovirus antigenemia. Rev inf Dis 1990 ; 12 (Suppl 7) : s737-44.
P.204 掲載の参考文献
2. 後藤憲彦, 平光高久, 渡井至彦, 打田和治. 腎移植希望患者に対する腎疾患早期からのB型肝炎ワクチンの必要性. 臨床腎移植学会症例集, 2010.
4. Danzinger-Isakov L, Kumar D. AST Infectious Diseases Community of Practice. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2009 ; 9 (Suppl 4) : S258.
5. Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Kidney Disease. Am J Transplant 2009 ; 9 (Suppl 3) : S1-155.
8. American Academy of Pediatrics. Immunocompromised children. In : Red Book : 2009 Report of the Committee on Infectious Diseases, 28th ed, Pickering LK (ed), Elk Grove Village : American Academy of Pediatrics 2009 : 72.
15. 後藤憲彦. 腎移植患者における帯状疱疹ワクチン予防ワクチン. 感染症学誌2011 ; 85 : 5 : 569.
P.211 掲載の参考文献
1. Hibberd PL, Rubin RH. Approach to immunization in the immunosuppressed host. Infect Dis Clin North Am 1990 ; 4 (1) : 123-42.
2. 平成21年度地域保健・健康増進事業報告地域保健・健康増進事業報告. 厚生労働省. http://www.e-stat.go.jp/SG1/estat/GL02020101.do?method=listDisplay&statCode=00450025&tstatCode=000001030884&tclass1=000001043472&tclass 2=000001043479&tclass 3=&tclass 4=&tclass 5=
4. 国立感染症研究所感染症情報センター http://idsc.nih.go.jp/index-j.html
5. Danzinger-Isakov L, Kumar D, et al. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2009 ; 9 (Suppl 4) : S258.
11. Prevots DR, Burr RK, Sutter RW, Murphy TV, Advisory Committee on Immunization Practices. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000 ; 49 (RR-5) : 1.
19. Sanchez-Fructuoso AI, Prats D, Naranjo P, Fernandez-Perez C, Gonzalez MJ, Mariano A, Gonzalez J, Figueredo MA, Martin JM, Paniagua V, Fereres J, Gomez de la Concha E, Barrientos A. Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols : mycophenolate versus azathioprine. Transplantation 2000 ; 69 (3) : 436.
25. Furth SL, Sullivan EK, Neu AM, Tejani A, Fivush BA. Varicella in the first year after renal transplantation : a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1997 ; 1 (1) : 37.
P.218 掲載の参考文献
7. Health Information for International Travel 2003-2004. Atlanta, Georgia : Centers for Disease Control, Department of Health and Human Services, 2003.
8. Rendi-Wagner P, Korinek M, Winkler B, Kundi M, Kollaritsch H, Wiedermann U. Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population. Vaccine 2007 ; 25 : 927-31
10. Gunther M, Stark K, Neuhaus R, Reinke P, Schroder K, Bienzle U. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation 2001 ; 71 : 477-9.
11. Kennedy SE, Shen Y, Charlesworth JA, et al. Outcome of overseas commercial kidney transplantation : An Australian perspective. Med J Aust 2005 ; 182 : 224-7.
12. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1993 ; 42 : 1-15.
13. Gibbons RV, Rupprecht CE. Postexposure rabies prophylaxis in immunosuppressed patients. JAMA 2001 ; 285 : 1574-75.
14. Conlon CP. The Immunocompromised Traveler. In : DuPont HL, Steffer R (eds) Textbook of Travel Medicine and Health. 2nd ed. B. C. Decker, 2001 : 464-9.
P.222 掲載の参考文献
3. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR recomm Rep 2000 ; 49 (RR-10) : 1-458, CE121-7.
4. Arendt RA, Morishita TY. Guide to pet care for immunocompromised. Ohiolone Fact Sheet. http://ohiolone.osu.edu
7. Alexander BD, Fishman JA. Prophylaxis of infections in solid organ transplantation. UpToDate 20.2, 2012
8. Pegues DA, Kubak BM, Maree CL, et al. Infections in kidney transplantation. Handbook of Kidney Transplantation 5th ed. Danovitch GM (ed), Philadelphia : Lippincott Williams & Wilkins, 2010 : 278-79.
9. 青木眞. 非定型抗酸菌症. レジデントのための感染症診療マニュアル 第2版, 東京 : 医学書院, 2008 : 795-8.
12. Yung AP, Grayson ML. Psittacosis--a review of 135 cases. Med J Aust 1988 ; 148 (5) : 228.
13. Hames A, Mumford J, Hale J, et al. Salmonella Michigan soft tissue infection in an immunocompromised child. J Clin Pathol 2008 ; 61 ; 773-4.
14. Amreeta D, Quek KF. Non-typhoidal Salmonella bacteremia : Epidemiology, clinicai characteristics and its'association with severe immunosuppression. Ann Clin Miclobiol Antimicrobials 2009 ; 8 : 15.
P.226 掲載の参考文献
1. Am J Transplant 2009 ; 9 (Suppl 4) : S263-66.
3. Ljutic D, Rumboldt Z. Possible interaction between azithromycin and cyclosporin : A case report. Nephron 1995 ; 70 : 130.
7. Lopez-Montes A, Gallego E, Lopez E, et al. Treatment of tuberculosis with rifabutin in a renal transplant recipient. Am J Kidney Dis 2004 ; 44 : e59-63.
9. Modry DL, Stinson EB, Oyer PE, Jamieson SW, Baldwin JC, Shumway NE. Acute rejection and massive cyclosporine requirements in heart transplant recipients treated with rifampin. Transplantation 1985 ; 39 : 313-4.
P.232 掲載の参考文献
5. Jensen PA, et al. Guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare settings, 2005. MMWR Recomm Rep 2005 ; 54 (RR-17) : 1-141.
7. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America : treatment of tuberculosis. Am J Respir Crit Care Med 2003 ; 167 : 603.
8. 後藤憲彦. 腎移植と結核-潜在性結核感染者に対する移植後モニタリング. 結核 2011 ; 86 (2) : 102-5.
11. 三田村敬子, 川上千春, 清水英明, 他. インフルエンザの診断法. 臨床と微生物 2010 ; 37 : 569-76.
17. Seigel JD, Reinhart E, Jackson M, Chiarella L. The Healthcare Infection Control Advisory Committee, 2007 Guideline for Isolation Precautions : Preventing Transmission of Infectious Agents in Healthcare Settings, 2007. http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf (Accessed on February 09, 2012).
19. Marin M, Guris D, Chaves SS, Schmid S, Seward JF ; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella : recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007 ; 56 (RR-4) : 1-40.

最近チェックした商品履歴

Loading...